Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01387555
Show Display Options
Rank Status Study
1 Unknown  A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   HCC
Interventions: Biological: JX-594 recombinant vaccina GM-CSF;   Other: Best Supportive Care

Indicates status has not been verified in more than two years